You should consider shares of JinkoSolar Holding Co. Ltd. (NYSE:JKS) and CME Group Inc. (NASDAQ:CME) if you are looking for a great stocks to invest in. Starting with the JKS shares, which traded at $18.57 at the close of the recent session, dropping -0.16%. On Tuesday, the company’s shares shed -$0.03 from its value which represented in intraday trading. The stock is now 60.50% higher in year-to-date (YTD) trading. JKS’s intraday high was $18.6463 while its lowest price touched $17.94. The stock’s 52-week high price is $24.84, which means the current price is at -25.24%. In terms of trading activity, the daily trading volume rose to 1277462 against 200-day average trading volume of 953,435 shares.
What are analyst forecasts for JinkoSolar Holding Co. Ltd. (NYSE:JKS)?
At a consensus rating of 3.00, JKS is trending as a streaking Hold, as it has been the case a month ago when 3 analysts called it a Hold. Two months ago, 3 analysts recommended, on average, that JKS stock is a Hold. The Technology company’s shares’ overall bearish trend saw it close higher on Tuesday compared to its opening price of $18.21 on the day.
Forecasts for JinkoSolar Holding Co. Ltd. (NYSE:JKS) give the stock a fair value for the growth of 88.98% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $168.57, which means the price per share could rise by nearly $150.0. The price range target is between a low of $98.50 and a high of $181.92. The stock would need to gain by about $89.79 to hit the estimated high or 0.5% from its 12-month low.
The consensus among 7 analysts is that it is a good time for one to Hold in the JinkoSolar Holding Co. Ltd. 2 analysts rate JKS as a Buy, with 1 of 7 analysts rate it as a Sell. 1 have valued the stock as Overweight and 3 have recommended that investors Hold.
JinkoSolar Holding Co. Ltd. (NYSE:JKS) Upgrades and Downgrades
In terms of rating changes, UBS on June 18, 2019, Downgrade JinkoSolar Holding Co. Ltd. (JKS) at Neutral. Analysts at ROTH Capital have assigned a Buy rating for the stock in their research note on February 04, 2019. Moreover, Williams Capital Group analysts issued a rating of Sell for the stock on December 19, 2018. On August 14, 2018, the stock earned a Neutral rating due to an analyst call from Citigroup, while analysts from ROTH Capital on June 04, 2018 suggested that the stock is Sell.
CME Group Inc. (NASDAQ:CME) adds $0.8 on Tuesday
The CME stock has risen 8.51% year-to-date and is currently trading at $204.12, which is -9.24% below its 52-week high. The company shares gained 0.39% on the day and have risen nearly 26.74% off a low hit. At current levels, CME Group Inc. has a valuation of about $4.97B. As of 12/03/19, this stock has fallen -1.30% during the week and closed at $203.32 in the previous session. However, recent CME Group Inc. stock performance shows that CME shares are 1.30% up over the last month, and -7.66% down for the last three months.
Earnings per share (EPS) estimates for the current quarter are $1.72, with the trailing 12-month share earnings at $5.69. The ratio is expected to be up by 1.30% for the current year 2019 and 7.40% for next year. Over the next 5-year period, earnings per share will be 6.42%. But will the CME stock surprise in the current quarter results, where the $1.9 actual EPS reported on 9/29/2019 surprised by 8.00% or was higher by $0.14 from the estimated $1.76.
Sales Growth to climb 5.00% for the year
How well will CME Group Inc. perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $1.07B and $1.26B in current quarter sales. The consensus estimated for the current quarter is $1.2B from sales. Forecasts for this fiscal year are between $4.8B and $4.99B and the consensus estimate for sales is at $4.93B. CME has its next quarter sales estimates at between $1.18B and $1.34B, with the quarter-over-quarter growth estimates at 5.80% and the annual growth forecast for the year at 5.00%.
Who owns shares in CME Group Inc. (CME)?
Let’s briefly focus on the share ownership of the CME Group Inc. (NASDAQ:CME) stock, where we find that 87.94% of shares are held by institutions. Capital World Investors tops the list of institutional owners as it is holding 35.58 million shares or 9.93% of shares outstanding. Vanguard Group, Inc. (The) and Blackrock Inc. held 28.24 million and 24.5 million representing 7.88% and 6.84% respectively at the close of the last trading session. As of Sep 29, 2019, State Street Corporation accounted for 16.36 million shares at over 3.46 billion. This represented 4.57% of shares outstanding. Capital International Investors held 13.47 million shares at over 2.85 billion representing 3.76% of shares outstanding.
CME Insider Activity
Insider activity can also give a signal in terms of price direction. Looking at CME Group Inc. (CME), a total of 95474 shares have been sold by insiders over the last 6 months while 91852 shares were added in the same time span. On 8/01/2019, Chairman & Chief Executive Officer by the name Duffy Terrence A sold 35000.0 shares worth $7.0 million at the price of $200.15 per share. Filings also show that Pietrowicz John W sold a total of 12060.0 shares on 1/02/2019 valued at $2.3 million. Since the last insider activity, the company’s share price has climbed 9.56%.